BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3133107)

  • 1. Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay.
    Chan PK; Aldrich MB; Chakrabarty S
    Cancer Lett; 1988 Jun; 40(2):143-9. PubMed ID: 3133107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular comparisons of acquired and native mitomycin C resistance in human colon carcinoma cells.
    Chakrabarty S; Brattain MG
    Cancer Lett; 1987 Nov; 37(3):267-76. PubMed ID: 3119191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
    Yung BY; Yang YH; Bor AM
    Int J Cancer; 1991 Jul; 48(5):779-84. PubMed ID: 2071236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
    Finch RA; Chan PK
    Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
    Chan PK
    Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar localization of nucleophosmin/B23 requires GTP.
    Finch RA; Revankar GR; Chan PK
    J Biol Chem; 1993 Mar; 268(8):5823-7. PubMed ID: 8095498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Bor AM; Chan PK
    Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular interaction and in vitro antitumor effect of various mitomycin C prodrugs in mitomycin C-resistant L1210 leukemia cell lines.
    Matsumoto S; Shigeoka T; Takakura Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3792-9. PubMed ID: 3124967
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence of cytosolic protein and phosphoprotein changes in human colon tumor cells with the development of resistance to mitomycin C.
    Taylor CW; Brattain MG; Yeoman LC
    Cancer Res; 1985 Sep; 45(9):4422-7. PubMed ID: 3928156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation.
    Chan PK; Aldrich M; Busch H
    Exp Cell Res; 1985 Nov; 161(1):101-10. PubMed ID: 2414117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
    Chan PK; Aldrich MB; Yung BY
    Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A B23-interacting sequence as a tool to visualize protein interactions in a cellular context.
    Lechertier T; Sirri V; Hernandez-Verdun D; Roussel P
    J Cell Sci; 2007 Jan; 120(Pt 2):265-75. PubMed ID: 17179202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
    Chan PK; Qi Y; Amley J; Koller CA
    Cancer Lett; 1996 Feb; 100(1-2):191-7. PubMed ID: 8620441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance.
    Dorr RT; Liddil JD; Trent JM; Dalton WS
    Biochem Pharmacol; 1987 Oct; 36(19):3115-20. PubMed ID: 3117061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamic intracellular distribution of nucleolar protein B23 in the interphase and mitotic cells of mammalian cultures].
    Zatsepina OV; Dudnik OA; Kudriavtsev IS
    Tsitologiia; 1996; 38(7):758-64. PubMed ID: 9005649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of quinone resistant cells to mitomycin C.
    Begleiter A; Robotham E; Lacey G; Leith MK
    Cancer Lett; 1989 Jun; 45(3):173-6. PubMed ID: 2471583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
    Dirix LY; Gheuens EE; van der Heyden S; van Oosterom AT; De Bruijn EA
    Anticancer Drugs; 1994 Jun; 5(3):343-54. PubMed ID: 7919460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
    Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
    Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.
    Yung BY; Busch H; Chan PK
    Biochim Biophys Acta; 1985 Dec; 826(4):167-73. PubMed ID: 3907710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.